ResearcherUniversity of LouisvilleActive in the last 2 years
Michelle M. Holland
Matched on ORCID iD 0000-0002-4917-9211; OpenAlex author ID A5044814780. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers · 2026: 1 paper
Papers 4
- Intersection of race and poverty for pancreatic adenocarcinoma: A public health crisis. First author DOI 10.1016/j.amjsurg.2025.116707↗
- Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: A Systemic Review and Meta-Analysis. First author DOI 10.1016/j.jss.2025.04.042↗
- Corrigendum to 'Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: A Systemic Review and Meta-analysis' Jou… First author DOI 10.1016/j.jss.2025.10.015↗
- A prospective, multi-institution assessment of irreversible electroporation for treatment of locally advanced pancreatic adenocarcinoma: initial outcomes from … Co-author DOI 10.1016/j.hpb.2018.12.004↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- John Bart Rose · 3 shared papers, 2025–2026 · strength 0.85
- Paper Intersection of race and poverty for pancreatic adenocarcinoma: A public health crisis. DOI 10.1016/j.amjsurg.2025.116707↗
- Paper Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: A Systemic Revie… DOI 10.1016/j.jss.2025.04.042↗
- Paper Corrigendum to 'Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: … DOI 10.1016/j.jss.2025.10.015↗
- Sushanth Reddy · 2 shared papers, 2025 · strength 0.54
- Paper Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: A Systemic Revie… DOI 10.1016/j.jss.2025.04.042↗
- Paper Corrigendum to 'Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: … DOI 10.1016/j.jss.2025.10.015↗
- Annabelle L. Fonseca · 2 shared papers, 2025 · strength 0.54
- Paper Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: A Systemic Revie… DOI 10.1016/j.jss.2025.04.042↗
- Paper Corrigendum to 'Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: … DOI 10.1016/j.jss.2025.10.015↗
- Chandler A. Annesi · 2 shared papers, 2025 · strength 0.54
- Paper Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: A Systemic Revie… DOI 10.1016/j.jss.2025.04.042↗
- Paper Corrigendum to 'Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: … DOI 10.1016/j.jss.2025.10.015↗
- Martin J. Heslin · 2 shared papers, 2025 · strength 0.54
- Paper Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: A Systemic Revie… DOI 10.1016/j.jss.2025.04.042↗
- Paper Corrigendum to 'Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: … DOI 10.1016/j.jss.2025.10.015↗
- Vikas Dudeja · 2 shared papers, 2025 · strength 0.54
- Paper Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: A Systemic Revie… DOI 10.1016/j.jss.2025.04.042↗
- Paper Corrigendum to 'Neoadjuvant Therapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: … DOI 10.1016/j.jss.2025.10.015↗
- Christopher Wu · 1 shared paper, 2026 · strength 0.32
- Andrea Gillis · 1 shared paper, 2026 · strength 0.32
- K Kerrick Akinola · 1 shared paper, 2026 · strength 0.32
- Neal Bhutiani · 1 shared paper, 2019 · strength 0.10
- John D. Christein · 1 shared paper, 2019 · strength 0.10
- Matthew John Weiss · 1 shared paper, 2019 · strength 0.10
- Kai‐Wen Huang · 1 shared paper, 2019 · strength 0.10
- Rebekah Ruth White · 1 shared paper, 2019 · strength 0.10
- Robert C.G. Martin · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.